In: Oncogene, 2021, vol. 40, no. 7, p. 1205–1216
Targeting the androgen receptor (AR) signaling axis has been, over decades, the mainstay of prostate cancer therapy. More potent inhibitors of androgen synthesis and antiandrogens have emerged and have been successfully i mplemented in clinical practice. That said, the stronger inhibition of the AR signaling axis has led in recent years to an increase of prostate cancers that de-differentiate...
|
In: Molecular Imaging and Biology, 2015, vol. 17, no. 5, p. 704-713
|
In: European Journal of Nuclear Medicine and Molecular Imaging, 2015, vol. 42, no. 10, p. 1574-1580
|
In: European Radiology, 2015, vol. 25, no. 8, p. 2222-2230
|
In: Clinical Chemistry and Laboratory Medicine, ///-
|
In: Abdominal Imaging, 2015, vol. 40, no. 6, p. 1352-1357
|
In: Lasers in Medical Science, 2015, vol. 30, no. 3, p. 1147-1151
|
In: World Journal of Urology, 2015, vol. 33, no. 4, p. 531-537
|
In: International Journal of Colorectal Disease, 2015, vol. 30, no. 12, p. 1667-1675
|
In: Molecular Imaging and Biology, 2015, vol. 17, no. 5, p. 735-744
|